RT Journal Article SR Electronic T1 CNV-ClinViewer: Enhancing the clinical interpretation of large copy-number variants online JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2022.03.23.22272818 DO 10.1101/2022.03.23.22272818 A1 Macnee, Marie A1 Pérez-Palma, Eduardo A1 Brünger, Tobias A1 Klöckner, Chiara A1 Platzer, Konrad A1 Stefanski, Arthur A1 Montanucci, Ludovica A1 Bayat, Allan A1 Radtke, Maximilian A1 Collins, Ryan L A1 Talkowski, Michael A1 Blankenberg, Daniel A1 Møller, Rikke S A1 Lemke, Johannes R A1 Nothnagel, Michael A1 May, Patrick A1 Lal, Dennis YR 2022 UL http://medrxiv.org/content/early/2022/03/23/2022.03.23.22272818.abstract AB Purpose Large copy number variants (CNVs) can cause a heterogeneous spectrum of rare and severe disorders. However, most CNVs are benign and are part of natural variation in human genomes. CNV pathogenicity classification, genotype-phenotype analyses, and therapeutic target identification are challenging and time-consuming tasks that require the integration and analysis of information from multiple scattered sources by experts.Methods We developed a web-application combining >250,000 patient and population CNVs together with a large set of biomedical annotations and provide tools for CNV classification based on ACMG/ClinGen guidelines and gene-set enrichment analyses.Results Here, we introduce the CNV-ClinViewer (https://cnv-ClinViewer.broadinstitute.org), an open-source web-application for clinical evaluation and visual exploration of CNVs. The application enables real-time interactive exploration of large CNV datasets in a user-friendly designed interface.Conclusion Overall, this resource facilitates semi-automated clinical CNV interpretation and genomic loci exploration and, in combination with clinical judgment, enables clinicians and researchers to formulate novel hypotheses and guide their decision-making process. Subsequently, the CNV-ClinViewer enhances for clinical investigators patient care and for basic scientists translational genomic research.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study used (or will use) ONLY openly available human data that were originally located at: - https://www.ncbi.nlm.nih.gov/clinvar/ (CNV data from ClinVar) -https://biobankenginedev.stanford.edu/downloads (CNV data from UK biobank) - https://gnomad.broadinstitute.org/downloads/ (gnomAD SV data) I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll code and data are accessible at https://github.com/LalReserachGroup/CNV-clinviewer